
12-month data from the BOLT study provides supporting evidence for the use of bevacizumab in patients with clinically significant DME.

12-month data from the BOLT study provides supporting evidence for the use of bevacizumab in patients with clinically significant DME.

An holistic approach that focuses on the healthy part of the cornea.

As a committed pioneer in the field of ophthalmology, Carl Zeiss Meditec supplies innovative technologiesand application-oriented solutions which enable doctors to improve the quality of life of their patients.

Femtosecond laser use on the up for flap creation is just one trend

Physicians must be aware of options, know how to use different categories of viscoelastic

Mapping epithelial thickness in patients with abnormal topography may rule out keratoconus

Left untreated, dry eye can cause many problems in the post operative period. As many as 33 million adults may be undiagnosed

Critical consideration based on the literature and studies

What guides a surgeon's choise?

Monovision popularity is growing as an option for presbyopia patients

Is monovision in your armamentarium?

Surgeons can now consider new treatment possibilities for patients that otherwise would have had limited options

Ophthalmic viscosurgical devices are designed to facilitate safety and control during phacoemulsification. But not all OVDs are created equal...

2009 heralded more interesting developments for ophthalmology. OTEurope asked some of Europe's leading key opinion leaders for their thoughts on the news and developments that generated most excitement or had most significance in the Cataract & Refractive sector

A procedure that uses microwaves to alter corneal refraction may be alternative to LASIK in myopia patients

Optic design modification enhances vision performance without degrading contrast sensitivity

Nowadays ophthalmic surgeons have several treatment options for astigmatism. In Dr Detlef Holland's refractive department toric IOL and LASIK are the main options used.

Tips and techniquess for cataract and refractive success: The dry eye connection.

More than 150 participants from 27 countries attended this year's SCHWIND User Meeting in Muscat, Oman.

A comparative evaluation of local anaesthesia for cataract surgery, published in The Journal of Cataract & Refractive Surgery says that randomized clinical trials are needed to facilitate statistical methods of metaanalysis to establish convincingly the overall benefits and efficacy of the various local anesthesia procedures in cataract surgery.

Crystalens AO is the first aberration-free accommodating IOL

Dr Bobby Qureshi, the first surgeon in the UK to carry out implant surgery using light adjustable lenses, he talks to OTEurope about the procedure

2009 heralded more interesting developments for ophthalmology. OTEurope asked some of Europe's leading key opinion leaders for their thoughts on the news and developments that generated most excitement or had most significance in the Cataract & Refractive sector

Rayner Intraocular Lens Limited, has marked a milestone with a celebration to honour the 60th anniversary of the implantation of the first intraocular lens (IOL) in a patient. The late Sir Harold Ridley implanted the first IOL on 29 November 1949 at St. Thomas Hospital in London. Due to the controversial nature of the surgery, this first surgery was conducted in almost total secrecy.

In the December issue of the American Journal of Ophthalmology Brandeis University researchers published a paper about the highly precise scleral lens, to treat severe cornea or ocular surface disease, the Boston Ocular Surface Prosthesis (BOS-P).